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Background
Risk prediction models that objectively quantify the probability or rate of clinically important events based on observable characteristics are critical tools for efficient patient care. A risk prediction model is typically constructed in a development sample, but before it is adopted for use, its performance needs to be assessed in an independent (external) validation sample. In examining validity, two fundamental aspects are discrimination and calibration. The former refers to the capacity of the model to properly stratify individuals with different risk profiles, and the latter refers to the degree to which predicted risks are close to their true counterparts (1) .
The Receiver Operating Characteristic (ROC) curve and its associated area under the curve (AUC, also known as the c-statistic) are classical examples of tools for assessing model discrimination. The ROC curve is often examined during both model development and validation, but the ROC curve based on the development sample and the ROC curve based on the validation sample may exhibit significant discrepancy. One area of interest in the present work is to understand the sources of discrepancy between the development and validation ROC curves. Previous work in this area has largely focused on the c-statistic, an overall summary measure of the ROC curve (2) (3) (4) . It has been argued that the discrepancy in c-statistic between the development and validation samples can have two major sources: potential differences in the distribution of predictor variables (case-mix), and potential misspecification of the risk prediction model in the validation sample (3) . As the former is a property of the sample, while the latter is an integral component of model validity, discerning these two sources of discrepancy can be informative.
Further, a crucial step when externally validating a risk prediction model is the assessment of its calibration. Compared to model discrimination, examining model calibration has not received the same level of attention (5, 6) , and for this reason, is referred to as "the Achilles' heel of predictive analytics" (7) . In the context of a logistic regression model for binary responses, Van Calster et al proposed a hierarchy of definitions for model calibration, with the first being the equivalence of the average values of the predicted and observed risks (mean calibration, or calibration-in-the-large) (8) . Weak calibration is achieved when there is no systematic overestimation or underestimation of risks at any levels of the predicted risk. Beyond this, a model is moderately calibrated if the average observed risk among all subjects with a given predicted risk is equal to the predicted risk. Finally, strong calibration is the equality of predicted and observed risks for each and every covariate pattern. However, Van Calster et al argue that strong calibration is unrealistic in practical situations. They show that moderate calibration is enough for a risk prediction model not to be associated with harm, and argue that aiming for moderate calibration is the most pragmatic approach in risk prediction (8) . Moderate calibration is typically assessed using the calibration plot, which visualizes the average value of the observed risk as a function of the predicted risk after grouping or smoothing the response values.
In this manuscript, we extend the previous work on model-based or case-mix-adjusted cstatistic to the entire ROC curve by proposing the model-based ROC (mROC) analysis. Instead of focusing on a summary measure, mROC enables investigators to disentangle the effect of casemix and model validity on the shape of the entire ROC curve during external validation.
Importantly, we show that moderate calibration is a sufficient condition for the convergence of empirical ROC and mROC curves in an independent sample. As such, the mROC connects the ROC analysis, a classical means of evaluating model discrimination, to model calibration. We use this connection to propose a novel test for statistical inference on model calibration based on mROC. The proposed test has two attractive properties: it can be performed alongside the popular and familiar ROC curve analysis, and it does not require specifying arbitrary quantities such as a smoothing bandwidth or the number of groups, as is required for traditional model calibration measures.
Notation and context
Our proposed methodology is applicable in a setting where the objective is to validate a previously developed risk prediction model for a binary outcome in a representative, independent 'external' sample. In the external dataset, let = ( 1 , … , ) be the binary outcome (or response) values (e.g., whether the disease will flare up in the next six months) for a random sample of independent individuals, with = 1 indicating presence of disease and = 0 indicating absence of disease. Through a previously developed risk prediction model, we obtain * = ( 1 * , … , * ), the vector of predicted risks from the model for this sample. In what follows, unless otherwise specified, by calibration we refer to moderate calibration, i.e.,
The empirical ROC curve
Two fundamental probability distributions underlie the ROC curve for a risk prediction model:
the distribution of the predicted risks among individuals who experience the event (positive individuals, or 'cases'), and among individuals who do not experience the event (negative individuals, or 'controls'). Let 1 and 0 represent the corresponding cumulative distribution functions (CDFs), and let be the binary event indicator:
Note that, the true positive (TP) and false positive (FP) probabilities are closely linked with the distribution of risk among the positive and negative individuals, respectively: ( ) ≡ ( * > | = 1) = 1 − 1 ( ), and ( ) ≡ ( * > | = 0) = 1 − 0 ( ). The population ROC curve induced by the risk prediction model * can be expressed as
where 0 ≤ ≤ 1 is the false positive probability (9) .
With the external dataset, consistent estimators for 1 and 0 can be obtained by averaging the indicators ( * ≤ ) for each of the positive and negative groups:
to generate ( ), the empirical ROC curve, as a consistent estimator of the population ROC curve (10, 11) .
The model-based ROC (mROC) curve
If the risk prediction model is calibrated, for the i th subject in the external sample, ( = 1| * ) = * ; thus, the vector of observed response values is a random draw of independent Bernoulli trials from the vector of predicted risks. Given this, one can study the 'expected' ROC curve that can be constructed by generating such random responses. Let * be a random realization of this potential outcome from the predicted risk of a randomly selected individual. The ROC-related CDFs for such potential outcomes are:
and ̅ 0 ( ) = ( * ≤ | * = 0).
Application of Bayes' rule leads to the following estimators in the external sample:
, and ̅ 0 ( ) = ∑ ( * ≤ ). Note that, for evaluating the CDFs ̅ 1 and ̅ 0 , we use all subjects included in the validation sample; in contrast, only predicted risks from positive subjects are used to obtain 1 whereas only predicted risks from negative subjects are used to obtain 0 . The observed outcomes in the validation sample do not appear in the expression of ̅ 1 and ̅ 0 . Therefore, the behavior of these CDFs depends on the predicted risks and in turn on the case-mix of the validation sample, rather than the observed outcomes. This is in contrast with the empirical ROC, where observed outcomes and case-mix (via the predicted probability) are used explicitly to estimate ̅ 1 and ̅ 0 . This distinction motivates our proposal for using mROC to discern the impact of calibration as we describe below.
mROC and model calibration
The limiting forms of the estimated CDFs ̅ 1 and ̅ 0 for the mROC are identified in Appendix 1. An important consequence is that, provided that the risk model is calibrated, ( ) and
( ) converge to the same value at each point , as , the sample size in the external sample, approaches infinity. That is, moderate calibration is a sufficient condition for asymptotic convergence of the empirical ROC and mROC curves. On the other hand, while any transformation that preserves the ranking of predicted risks will result in the same ROC curve, the mROC curve is affected by the value of the risks and will generally change under such transformations. Thus, mis-calibrated models will generally result in divergent mROC and ROC curves.
To illustrate this, consider the simple situation when the true risk, represented by , has a standard uniform distribution in the population:
We consider three scenarios: the 'correct specification' scenario, when the prediction model correctly estimates the true risk ( * = ) and thus is calibrated, and under two alternative scenarios of overestimation ( * = √ ) and underestimation ( * = 2 ) of the true risks. For these three scenarios, the analytical forms of the population-based CDFs 1 ( ), 0 ( ) , ̅ 1 ( ), and ̅ 0 ( ) are provided in Table 1 . 
For all three scenarios, given that the predicted risks are monotonically transformed versions of the true risk, the population-based ROCs are the same: ( ) = 2 √ − . However, ( ) = ( ) only for the correct specification scenario. For the two alternative scenarios, closed-form expressions for ( ) are not available, but the single root for 
mROC as the basis of a novel statistical test for model calibration
As we demonstrate in Appendix 1, moderate calibration is a sufficient condition for the convergence at all points of the empirical ROC and mROC curves. However, moderate calibration on its own is not a necessary condition for such convergence. To progress, in Appendix 2 we show that at the population level, the equivalence of ROC and mROC curves guarantees moderate calibration if an additional condition is imposed. This condition is mean calibration, i.e., ( * ) = ( ), a condition whose assessment is an integral part of external validation of a risk prediction model (12) .
While such equalities can hold at the population level, it is unrealistic to expect equivalence, either between the average predicted and observed risks, or between the empirical ROC and mROC curves, within a finite sample. Therefore, an objective assessment could be difficult to carry out in practice using the graphical approach described in the previous section. Instead, we propose a statistical inference procedure to test hypotheses about corresponding population quantities. We define the null hypothesis ( Given the developments in Appendix 2, these hypotheses jointly provide the necessary and sufficient conditions for the risk prediction model to be calibrated. , which achieves its minimum value of 0 when the ROC and mROC curves are equal at all points. Our proposed test statistic is a sample estimator for this quantity, the integrated absolute difference between the empirical ROC and mROC curves in the validation sample:
(ROC equality statistic).
Given that both and are step functions, the above integral is the sum of rectangular areas and can be precisely evaluated. the same in all simulations as it is solely a function of predicted risks and not responses). These empirical distributions can then be used to generate approximate one-tailed p-values for these two statistics as:
where is the empirical CDF of the mean calibration statistic under 0 , and would have a chi-square distribution with 4 degrees of freedom (13) . However, as the two statistics are generated from the same data, they are dependent. The adaptation of Fisher's method for dependent p-values can be used (14) . This requires evaluating the expectation and variance of under the null hypothesis, matching these moments to approximate the null distribution of as that of a constant times a chi-square random variable, and modifying the test statistic and degrees of freedom of the chi-square reference distribution accordingly.
Because our Monte Carlo simulation provides many observations from the joint distribution of and , these correction factors can easily be obtained from the same simulated samples.
The steps for generating a unified p-value are outlined in the algorithm provided in Supplementary Material -Section 1.
A brief simulation study
We have conducted simulation studies to evaluate the performance of our proposed test. The simulation setup was similar to the earlier stylized example: we modeled a single predictor with a standard normal distribution, and the true risk as = 1/(1 + (− )), resulting in the population average response probability of 0.5. We then evaluated the performance of the test The unified test was the only test that rejected 0 with power >0.05 in all other scenarios.
Focusing on the third row, where 0 = 0, given that the distributions of predicted risks are symmetric around 0.5, ( * ) = ( ) = 0.5 under these scenarios, and fails. On the other hand, in the third column, where 1 = 1 (thus the predicted odds are proportional to the true odds), largely fails (the mROC and ROC curves are very close to each other under this scenario, as seen in Figure 4 ). Individuals vary widely in their tendency to exacerbate (15) . Around 20% of exacerbations are severe, which means they require inpatient care (16) . Predicting who is likely to experience an exacerbation, especially a severe one, will provide opportunities for preventive interventions.
We demonstrate an application of mROC and our proposed test using data from two clinical trials of medications to prevent exacerbation in COPD patients.
MACRO was a clinical trial that investigated whether daily use of azithromycin, a broadspectrum antibiotic, can decrease the rate of exacerbations (17) . STATCOPE was a clinical trial of daily statin therapy for reduction of exacerbation rate (18) . The benefit-harm of such preventive therapies can be more favorable in patients who will have more exacerbations in the future. As such, predicting the future exacerbation risk can enable more informed treatment decisions.
We used data from MACRO to create a risk prediction model for the six-month risk of experiencing at least one exacerbation. We used the STATCOPE sample for external validation.
Because dealing with the nuances of developing a risk prediction model is beyond the scope of this work, we have made simplifying assumptions and approaches (treating missing data and censoring as random, and not applying penalization in fitting the models We used a logistic regression model that included the predictors as listed in Table 2 based on a priori list of covariates selected based on prior knowledge of possible association with the outcome. We included a coefficient for randomized treatment (azithromycin) but it was set to 0 for prediction (as the model is applicable to those who are not on preventive therapy, and none of the individuals in the validation sample was on such a therapy). Maximum likelihood estimates of regression coefficients were used to construct the prediction score. We further developed a model only for severe exacerbations using the same approach. The linear predictors for both final risk prediction models are provided in Table 2 . to the development ROC curve but not to the external ROC curve. This indicates that the reduction in the discriminatory performance of the model is due to mis-calibration. Indeed, mean calibration was rejected (̂( * ) = 0.671; ̂( ) = 0.546; < 0.001; a two-tailed ttest also had p<0.001), as well as the equivalence of the mROC and external ROC curves (p<0.001). The unified test also rejected the hypothesis that the model is calibrated (p<0.001).
The calibration plot showed severe mis-calibration in the validation sample, with a general overestimation of the risk. : area under the curve (c-statistic) in the validation sample;
: area under the model-based ROC curve; : Mean calibration statistic; : ROC equality statistic;
: p-value of the mean calibration test; : p-value for the ROC equality test;
: p-value of the unified test
The model for severe exacerbations had higher discriminatory power compared with all exacerbations. All three ROC curves were generally aligned with each other. Here, mean calibration was not rejected at 0.05 level (̂( * ) = 0.107; ̂( ) = 0.088; = 0.071; a twotailed t-test generated a p-value of 0.061). The ROC equality test was also not significant (p=0.735). The unified test for model calibration did not reject the hypothesis that the model is calibrated (p=0.202). The calibration plot demonstrated generally good agreement between the predicted and observed risks for all but the highest decile (Figure 6 ).
Discussion
Our contribution in this work was the introduction of model-based ROC (mROC) analysis, the ROC curve that should be expected if the model is at least moderately calibrated in an external validation sample. We showed moderate calibration is a sufficient condition for the convergence of empirical ROC and mROC curves. We extended these results by proving that together, mean calibration and the equivalence of mROC and ROC curves in the population, are sufficient conditions for the model to be at least moderately calibrated. To test for such an equivalence within a sample, we suggested a simulation-based test. These results yield two connected applications. First, the mROC can be used to examine the potential role of case-mix versus model calibration when evaluating the discriminatory performance of a risk prediction model in a new sample. Second, the mROC provides a novel method for statistical inference on model calibration. To the best of our knowledge, this is the first time that the ROC plot, a classical means of communicating model discrimination, has been connected to model calibration. Given the vast popularity of ROC curves compared with calibration curves, this has the potential to facilitate examining model calibration, which is often neglected when developing risk prediction models (7) .
In the context of logistic regression, there are several approaches to examine how well the model fits the data. Allison reviewed several such tests and classified them into measures of predictive power (metrics similar to 2 ) and goodness-of-fit tests (e.g., the Hosmer-Lemeshow test) (19) . Our proposed test assesses model calibration, which makes it partially related to the latter. The test that is the most associated with calibration plots is the Hosmer-Lemeshow test, which is criticized due to its sensitivity to the grouping of the data, and lack of information about direction of mis-calibration (19) . Our proposed test is free from arbitrary grouping of the data or the choice of smoothing factors. It provides information on mean calibration as well as mROC and ROC curve compatibility, which can be interpreted separately. Our brief simulations empirically assessed the postulated properties of this novel test in various sample size settings.
The proposed methodology for examining model calibration can also be compared against scalar metrics that are applied to the calibration plot. One such metric is Harrell's Emax statistic, defined as the maximum absolute difference between the calibration plot and the diagonal line (20) . Recently, Austin and Steyerberg proposed the integrated calibration index (ICI), the average absolute distance of the calibration plot from the diagonal line when the response values are smoothed, with weights given by the probability distribution of predicted risks (21) .
Both Emax and ICI require smoothing of the calibration plot. On the other hand, while Emax and ICI have direct interpretations on the calibration plot, the mROC methodology does not provide a similarly interpretable scalar index. Rather, it breaks up the calibration assessment into the two metrics of mean calibration and ROC/mROC compatibility, which are interpretable on their own. These previous authors did not discuss statistical inference for Emax and ICI. One can conceive asymptotic or simulation-based methods for determining the distribution of Emax and ICI under the null hypothesis that the model is calibrated. The comparative performance of such tests and our proposed test needs to be studied in the future.
In the developments proposed in this work, we focused on applying the mROC methodology to an independent validation sample. It will be tempting to compare the mROC and ROC curves within the development dataset. In many situations (e.g., logistic regression models), maximum likelihood estimation guarantees mean calibration in the sample. As such, comparing the ROC and mROC curves in this case might seem sufficient for demonstrating moderate calibration. A visual comparison of the mROC and ROC curves in the development sample can indeed provide subjective clues about the compatibility of the model with the data (e.g., the choice of the link function). Care should be taken, however, in statistical inference for such a comparison. Given that the predicted probabilities are estimated from the same data, the vector of responses is not a random draw from the vector of predicted probabilities (a fundamental notion justifying the construction of mROC). As such, the distribution of the p-values for the mean calibration and ROC equality statistics under the null hypothesis will not be uniform.
There are several ways the proposed methodology can be extended. We only focused on binary outcomes without censoring. The ROC curve has been extended to categorical data (22) , as well as to time-dependent data (23) ; similar developments can also be pursued for the mROC methodology. We considered it to be beyond the scope of this paper to compare the Proof: A pre-specified risk prediction model * ( ) yields predicted risks * ≡ * ( ), where is the vector of predictors for the i th individual. When sampling from a population, the mapping from to * is known, but * for the i th individual is random as is randomly selected. For any value of the predicted risk * , there is a unique 'calibrated risk' given by the true risk of the outcome among all individuals with that predicted risk: ≡ ( * ) = ( = 1| * ( ) = * ). A model is moderately calibrated when ∀ , ( ) = .
We first consider the behavior of 1 ( ). For each fixed value of , 1 ( ) is the average of ( * ≤ ) among individuals with = 1. Hence, provided ( = 1) > 0, dividing both the numerator and denominator of the expression for 1 ( ) in the main text by and applying the Weak Law of Large Numbers yields (in what follows, an arrow denotes convergence in probability as the sample size n approaches infinity), we have:
[ ( * ≤ ). ] ( ) = ( * ≤ , = 1) ( = 1) = ( * ≤ | = 1) = 1 ( ).
Bayes' rule allows this limit to be re-expressed as:
( * ≤ | = 1) = ( = 1 | * ≤ ). ( * ≤ ) ( = 1) .
Proceeding similarly for ̅ 1 ( ) leads to: Similar arguments apply for 0 ( ) and ̅ 0 ( ), thereby establishing the desired result. Given that the result to be established is concerned with population quantities, in place of the CDFs 1 ( ), 0 ( ), ̅ 1 ( ), and ̅ 0 ( ) that underlie the empirical ROC and mROC curves, we use the limiting versions of these CDFs.
For the ROC curve, we can express the underlying CDFs as .
For the sake of simplicity and avoiding technicalities around the behavior of the quantile function for discrete distributions, the proof presented here is for the common case where * (⋅ ) is a strictly increasing function without jumps (equivalently, it has a corresponding probability density function having no intervals with zero density). This is the case, for example, for typical logistic regression models when there is at least one continuous predictor with unrestricted range. Given this condition, ̅ 1 ( ) and ̅ 0 ( ) are strictly increasing (without jumps) on [0,1] and, with the additional technical condition that 0 < ( ) < 1 (the true risk is not strictly 0 or 1 at any level of predicted risk), so too are 1 ( ) and 0 ( ).
With these expressions, we can re-express the result to be established as . Let = ( ) = ̅ 0 −1 (1 − ) and = ( ) = 0 −1 (1 − ) ; it follows that ̅ 0 ( ) = 0 ( ). Then Condition 2, and the strictly increasing nature of the CDFs, imply:
̅ 0 ( ) = 0 ( ) ⇔ ̅ 1 ( ) = 1 ( ).
The expressions above for these CDFs yield the equivalent statement (after making use of 2. For i=1 to N (number of simulations):
2.1. Generate a random response vector * from the predicted risks * .
2.2. Calculate 0 and 0 from * and * and store their values.
3. Based on the 0 and 0 , construct the empirical CDFs (. ) and (. ). 
Calculate

